Literature DB >> 27873542

A 6-year surveillance study of "Stingers" in NCAA American Football.

James Green1, Scott L Zuckerman2, Sara L Dalton3, Aristarque Djoko4, Dustin Folger4, Zachary Y Kerr4.   

Abstract

This study describes the epidemiology of "stinger" injuries in National Collegiate Athletic Association (NCAA) Men's Football. About 57 NCAA Men's Football programmes provided 153 team-seasons of injury data to the NCAA Injury Surveillance Programme (NCAA-ISP) during the 2009/2010-2014/2015 academic years. In the study period, 229 "stingers" were reported for an injury rate of 2.04/10,000 athlete-exposures (AE). Most "stingers" were reported during competitions (55.5%) and the preseason (80.3%) and resulted in time loss less than 24 hours (63.8%). One in five (18.8%) were recurrent. Most "stingers" were due to player contact (93.0%), particularly while tackling (36.7%) and blocking (25.8%) and occurred to defensive ends/linebackers (25.8%) and offensive linemen (23.6%). Although previous research reports a large prevalence of "stingers" among football players, the NCAA-ISP reported a relatively low injury rate. The transient nature of pain associated with "stingers" may have contributed to under-reporting, highlighting the need to deduce manners to increase reporting.

Entities:  

Keywords:  Epidemiology; burners; injury surveillance; neurologic injury; stingers

Mesh:

Year:  2016        PMID: 27873542     DOI: 10.1080/15438627.2016.1258642

Source DB:  PubMed          Journal:  Res Sports Med        ISSN: 1543-8627            Impact factor:   4.674


  2 in total

1.  REHABILITATION OF CHRONIC BRACHIAL PLEXUS NEUROPRAXIA AND LOSS OF CERVICAL EXTENSION IN A HIGH SCHOOL FOOTBALL PLAYER: A CASE REPORT.

Authors:  Ryan A Hartley; Michael E Kordecki
Journal:  Int J Sports Phys Ther       Date:  2018-12

2.  Sports Injury Epidemiology: Foundation of Evidence of, by, and for Athletic Trainers.

Authors:  Jennifer M Medina McKeon; Patrick O McKeon; Aliza K Nedimyer
Journal:  J Athl Train       Date:  2021-07-01       Impact factor: 3.824

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.